Presence of Government-funded Entities in Foot and Mouth Disease (FMD) Vaccines Market Compels Private Players to Innovate, says TMR Date: 03-01-2017 09:30 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Pharmaceutical
The top three players in the global Foot and Mouth Disease (FMD) such as Merial, MSD Animal Health (Merck), and Bayer AG account for 74.6% of the overall market. However, the global FMD market is highly fragmented due to the presence of many local players, reports Transparency Market Research (TMR) in a new study. Some of the local players are Agrovet, Brilliant Bio Pharma Ltd., Centro Diagnóstico Veterinario, Intervac (PVT) Ltd., Inova Biotecnologia Saúde Animal Ltda., Razi Vaccine & Serum Research Institute and Indian Immunologicals Limited. “The manufacturers are competing not only with private players, but also governments of many countries who have set up their own FMD vaccines manufacturing units,” says the author of the report. Download Exclusive Brochure of This Report : www.transparencymarketresearch.com/sample/sample.php?flag... Growing Consumption of Meat in European Countries Boosts the Demand for FMD Vaccines India, China, and Hong Kong are the top three countries of Asia involved in the export of beef and pork. Denmark, France, and Spain import most of their meat products from Asia. Thus, augmenting export of meat products increases the requirement of healthy livestock, thereby fueling the demand for FMD vaccines. Countries in Asia and Africa encounter FMD outbreaks at an alarming rate. The governments of these countries are, thus, taking certain initiatives to control FMD outbreaks. Hence, favorable government initiatives are likely to accentuate the demand of FMD vaccines. A latest trend observed in the FMD vaccines market is the development of DNA vaccines. These vaccines provide better results and have a longer lasting effect than the conventional vaccines. Therefore, manufacturers are financing these vaccines in order to generate more revenue. Government Intervention in Distribution Reduces the Cost of Vaccine
Seite 1 / 3